![David Bryant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Bryant
Director/Board Member at
AVACTA GROUP PLC
Net worth: 145 482 $ as of 2026-09-29
Profile
David Bryant currently works at Avacta Group Plc, as Independent Non-Executive Director from 2025 and Berry Capital Management LLC, as Director.
Mr. Bryant also formerly worked at Wyeth Pharmaceuticals LLC, as Commercial Director-EMEA Region, Clinigen Ltd., as Director from 2023 to 2024, Glaxo Wellcome Plc, as Principal, GSK Plc, as Principal, and GlaxoSmithKline Services Unlimited, as Business Manager.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVACTA GROUP PLC 0.03% | 2026-10-05 | 152,894 ( 0.03% ) | 145 482 $ | 2026-09-29 |
David Bryant active positions
| Companies | Position | Start |
|---|---|---|
| AVACTA GROUP PLC | Director/Board Member | 2025-05-27 |
Berry Capital Management LLC
 Berry Capital Management LLC Investment ManagersFinance Provides investment advisory services | Director/Board Member | - |
Former positions of David Bryant
| Companies | Position | End |
|---|---|---|
| CLINIGEN GROUP PLC | Chief Executive Officer | 2023-01-02 |
GlaxoSmithKline Services Unlimited
 GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| GSK PLC | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Glaxo Wellcome Plc
Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
GlaxoSmithKline Services Unlimited
GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical services company that engages in clinical trails, regulatory affairs, distribution and commercialization of pharma companies | Commercial Services |
Berry Capital Management LLC
Berry Capital Management LLC Investment ManagersFinance Provides investment advisory services | Finance |
- Stock Market
- Insiders
- David Bryant
